A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron.

Bah, A; (2019) A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron. PhD (research paper style) thesis, London School of Hygiene & Tropical Medicine. DOI: https://doi.org/10.17037/PUBS.04655033

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.17037/PUBS.04655033

Abstract

Item Type Thesis
Thesis Type Doctoral
Thesis Name PhD (research paper style)
Contributors Moore, SE and Prentice, AM
Faculty and Department Faculty of Epidemiology and Population Health > Dept of Population Health (2012- )
Research Group Medical Research Council Unit, The Gambia at the London School of Hygiene & Tropical Medicine
Funders UK Medical Research Council (MRC) and the UK Department for International Development (DFID), under the MRC/DFID Concordat agreement to the MRC International Nutrition Group
Grant number MC-A760-5QX00
Copyright Holders Amat Bah

Share

Download

Filename: 2019_EPH_PhD_Bah_A_FINAL.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar